Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life.
Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination.
Headaches in multiple sclerosis patients might imply an inflammatorial process.
Systematic Review of the Epidemiology of Urinary Incontinence and Detrusor Overactivity among Patients with Neurogenic Overactive Bladder.
Predictors of executive complaints and executive deficits in multiple sclerosis.
MicroRNA-23a promotes myelination in the central nervous system.
Multiple sclerosis starting before the age of 18 years: the Brazilian experience.
Uptake of environmental toxicants by the locus ceruleus: A potential trigger for neurodegenerative, demyelinating and psychiatric disorders.
Newer therapies for multiple sclerosis.
Season of birth and multiple sclerosis in Tunisia.
Specificities of children with multiple sclerosis and neuromyelitis optica.
Beclin 1 regulates neuronal transforming growth factor-β signaling by mediating recycling of the type I receptor ALK5.
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Nongenomic actions of neurosteroid pregnenolone and its metabolites.
Requirement of CD30 expression on CD4 T cells in the pathogenesis of experimental autoimmune encephalomyelitis.
Inhibition of phosphoinositide 3-kinase delta attenuates experimental autoimmune encephalomyelitis in mice.
Role of neuroinflammation in neurodegenerative diseases (Review).
Hes3 expression in the adult mouse brain is regulated during demyelination and remyelination.
Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus (TMEV) infection.
Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain.
A role for Apolipoprotein A-I in the pathogenesis of multiple sclerosis.
Complex I Subunit Gene Therapy with NDUFA6 Ameliorates Neurodegeneration in EAE.
Correction to Imidazol-1-ylethylindazole Voltage-Gated Sodium Channel Ligands Are Neuroprotective during Optic Neuritis in a Mouse Model of Multiple Sclerosis.
The best clinical paper on multiple sclerosis in 2014.
Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
647
648
649
650
651
652
653
654
655
…
next ›
last »